SCIESCOPUSQ2
Clinical Lung Cancer
CIG MEDIA GROUP, LP, United States
Clinical Lung Cancer is an academic journal published by CIG MEDIA GROUP, LP (United States). Identifiers: ISSN 1525-7304, eISSN 1938-0690. Indexed in SCIE, SCOPUS. Metrics: JIF 3.3, CiteScore 6.7, SJR 1.515, SNIP 0.86. Subject areas: ONCOLOGY. tlooto lists 3,132 papers from this journal.
CiteScore
6.70
Scopus citation metric
SJR
1.515
SCImago rank
SNIP
0.86
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1525-7304
- eISSN
- 1938-0690
- Abbreviation
- CLIN LUNG CANCER
- Publisher
- CIG MEDIA GROUP, LP
- Country
- United States
Web of Science categories
SCIEONCOLOGY
Scopus ASJC categories
1306 Cancer Research2730 Oncology2740 Pulmonary and Respiratory Medicine
Keywords
Oncology
Papers in this journal
Recent papers
- Immune Checkpoint Inhibitors in Unresectable or Metastatic Thymic Epithelial Tumors--A Real-World Assessment of Efficacy and Toxicity.
2026
- A Retrospective, Multicenter Analysis Within the National Network Genomic Medicine Lung Cancer in Germany to Detect RET Fusions as a Possible Mechanism of Resistance in Patients With EGFR Mutations.
2026
- Pembrolizumab Plus Platinum Doublet Chemotherapy With Lenvatinib in Unresectable Pleural Mesothelioma as First-Line Treatment (PENINSULA): A Study Protocol for a Single-Arm, Multi-Institutional, Phase II Clinical Trial.
2026
- Management of Pulmonary Large-Cell Neuroendocrine Carcinoma (LCNEC): An Updated Review.
2026 · 1 citations
- Coopting Germline BRCA2 Mutation With an Available PARP Inhibitor to Manage Resistance to EGFR Targeted Therapy in EGFR-Mutated Lung Cancer: Combination of Olaparib With Osimertinib.
2026
Most cited papers
- Exosomal microRNA: a diagnostic marker for lung cancer.
2008 · 1,276 citations
- Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancers Dependent on the Epidermal Growth Factor Receptor Pathway
2009 · 446 citations
- An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer.
2014 · 403 citations
- Radiomic features are associated with EGFR mutation status in lung adenocarcinomas
2016 · 275 citations
- Emotional Problems, Quality of Life, and Symptom Burden in Lung Cancer Patients
2017 · 267 citations